ArticleOncogene2018

Insertional mutagenesis in a HER2-positive breast cancer model reveals ERAS as a driver of cancer and therapy resistance.

Gerjon J Ikink et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.